DIADON

This brand name is authorized in Nigeria.

Active ingredients

The drug DIADON contains one active pharmaceutical ingredient (API):

1	Loperamide UNII 77TI35393C - LOPERAMIDE HYDROCHLORIDE
	By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency.
	Read more about Loperamide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-0107	Capsule	DIADON CAPSULES CAP 2 mg 1X10CAPSULES	76 CMS-PP-372893 DIADON CAPSULES LOPERAMIDE HCL 2MG loperamide hydrochloride capsule usp 2mg. Other ingredients- maize starch, lactose, dicalcium phosphate, sodium laural sulphate, sodium starch glycolate, Magnesium sterate. A4-0107 Drugs Imported Products 1X10CAPSULES Over The Counter (OTC) 11/5/2023 MAYDON PHARMACEUTICAL LIMITED., WILMER STREET, OFF TOWN PLANNING, ILUPEJU, LAGOS LAGOS 1740194511 maydonp@outlook.com MAXHEAL LABORATORIES PVT LTD, PLOT NO. 2-7/80-85 SURSEZ SACHIN DIST. SURAT GUJARAT 394 230 INDIA, India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07DA03	Loperamide	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-0107